Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function

被引:50
|
作者
Comita, Stefano [1 ]
Femmino, Saveria [2 ]
Thairi, Cecilia [1 ]
Alloatti, Giuseppe [3 ]
Boengler, Kerstin [4 ]
Pagliaro, Pasquale [1 ]
Penna, Claudia [1 ]
机构
[1] Univ Turin, Dept Clin & Biol Sci, Reg Gonzole 10, I-10043 Turin, Italy
[2] Univ Turin, Dept Med Sci, Turin, Italy
[3] Polo Univ Rita Levi Montalcini, Uni Astiss, Asti, Italy
[4] Univ Giessen, Inst Physiol, Giessen, Germany
关键词
Ca2+ regulation; Ischemia reperfusion injury; Mitochondrial permeability transition pore; Reactive oxygen species; RISK pathway; SAFE pathway; STAT3; STAT5; ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; ELECTRON-TRANSPORT CHAIN; ARTERY-BYPASS SURGERY; ISOLATED RAT-HEART; SIGNAL TRANSDUCER; TNF-ALPHA; SERINE PHOSPHORYLATION;
D O I
10.1007/s00395-021-00898-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ischemia-reperfusion injury (IRI) is one of the biggest challenges for cardiovascular researchers given the huge death toll caused by myocardial ischemic disease. Cardioprotective conditioning strategies, namely pre- and post-conditioning maneuvers, represent the most important strategies for stimulating pro-survival pathways essential to preserve cardiac health. Conditioning maneuvers have proved to be fundamental for the knowledge of the molecular basis of both IRI and cardioprotection. Among this evidence, the importance of signal transducer and activator of transcription 3 (STAT3) emerged. STAT3 is not only a transcription factor but also exhibits non-genomic pro-survival functions preserving mitochondrial function from IRI. Indeed, STAT3 is emerging as an influencer of mitochondrial function to explain the cardioprotection phenomena. Studying cardioprotection, STAT3 proved to be crucial as an element of the survivor activating factor enhancement (SAFE) pathway, which converges on mitochondria and influences their function by cross-talking with other cardioprotective pathways. Clearly there are still some functional properties of STAT3 to be discovered. Therefore, in this review, we highlight the evidence that places STAT3 as a promoter of the metabolic network. In particular, we focus on the possible interactions of STAT3 with processes aimed at maintaining mitochondrial functions, including the regulation of the electron transport chain, the production of reactive oxygen species, the homeostasis of Ca2+ and the inhibition of opening of mitochondrial permeability transition pore. Then we consider the role of STAT3 and the parallels between STA3/STAT5 in cardioprotection by conditioning, giving emphasis to the human heart and confounders.
引用
收藏
页数:31
相关论文
共 27 条
  • [21] The role of lnc-DC long non-coding RNA and SOCS1 in the regulation of STAT3 in coronary artery disease and type 2 diabetes mellitus
    Alikhah, Asieh
    Kakhki, Majid Pahlevan
    Ahmadi, Amirhossain
    Dehghanzad, Reyhaneh
    Boroumand, Mohammad Ali
    Behmanesh, Mehrdad
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (03) : 258 - 265
  • [22] Long non-coding RNA EGFR-AS1 in colorectal cancer: potential role in tumorigenesis and survival via miRNA-133b sponge and EGFR/STAT3 axis regulation
    Atef, M. M.
    Amer, A., I
    Hafez, Y. M.
    Elsebaey, M. A.
    Saber, S. A.
    Abd El-Khalik, S. R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2021, 78 (03) : 122 - 129
  • [23] Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR
    Li, Bin
    Ding, Cui-Min
    Li, Yan-Xiao
    Peng, Jing-Cui
    Geng, Nan
    Qin, Wen-Wen
    ONCOLOGY REPORTS, 2018, 39 (03) : 1227 - 1234
  • [24] Role of STAT3 (signal transducer and activator of transcription 3) activation and its regulation by PTPRT (protein receptor tyrosine phosphatase type T) and response to paclitaxel and cetuximab in patients (P) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Cirauqui Cirauqui, B.
    Bernat Peguera, A.
    Quer Pi-Sunyer, A.
    Ramirez Serrano, J. L.
    Domenech Vinolas, M.
    Teruel Garcia, I.
    Quiroga Garcia, V.
    Margeli Vila, M.
    Chaib, I.
    Capdevila Riera, L.
    Ferrando Diez, A.
    Plaja Salarich, A.
    Angelats Company, L.
    Espana Fernandez, S.
    Berenguer Peinado, G.
    Lezcano Rubio, C.
    Pollan Guisasola, C.
    Martinez Cardus, A.
    Rosell Costa, R.
    Mesia Nin, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S681 - S681
  • [25] RETRACTED: Long non-coding RNA XIST binding to let-7c-5p contributes to rheumatoid arthritis through its effects on proliferation and differentiation of osteoblasts via regulation of STAT3 (Retracted article. See vol. 36, 2022)
    Wang, Zong-Qiang
    Xiu, Dian-Hui
    Jiang, Jin-Lan
    Liu, Gui-Feng
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (11)
  • [26] RETRACTION: Long non-coding RNA XIST binding to let-7c-5p contributes to rheumatoid arthritis through its effects on proliferation and differentiation of osteoblasts via regulation of STAT3 (Retraction of Vol 34, art no E23496, 2020)
    Wang, Zong-Qiang
    Xiu, Dian-Hui
    Jiang, Jin-Lan
    Liu, Gui-Feng
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (01)
  • [27] Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations
    Pilotto, S.
    Grizzi, G.
    Sperduti, I.
    Simbolo, M.
    Vicentini, C.
    Calio, A.
    Caccese, M.
    Mafficini, A.
    Carbognin, L.
    Corbo, V.
    Gkountakos, A.
    Santo, A.
    Infante, M.
    Brunelli, M.
    Scarpa, A.
    Tortora, G.
    Bria, E.
    ANNALS OF ONCOLOGY, 2018, 29